Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Smoldering Systemic Mastocytosis (SSM)”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableStudy completedNCT02620254
What this trial is testing

Mast Cell Connect: A Registry for Patients With Mastocytosis

Who this might be right for
Mastocytosis
Blueprint Medicines Corporation 743
Testing effectiveness (Phase 2)Active Not RecruitingNCT05186753
What this trial is testing

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
SSMMastocytosis, IndolentMastocytosis, Systemic+5 more
Cogent Biosciences, Inc. 237
Testing effectiveness (Phase 2)Active Not RecruitingNCT03731260
What this trial is testing

(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
Blueprint Medicines Corporation 251
Large-scale testing (Phase 3)Looking for participantsNCT04910685
What this trial is testing

(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic MastocytosisSmoldering Systemic Mastocytosis
Blueprint Medicines Corporation 534
Not applicableStudy completedNCT02380222
What this trial is testing

Patient-Reported Outcome Questionnaire for Systemic Mastocytosis

Who this might be right for
Aggressive Systemic Mastocytosis (ASM)SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD)Mast Cell Leukemia (MCL)+2 more
Adelphi Values LLC 5
Testing effectiveness (Phase 2)UnknownNCT01920204
What this trial is testing

Midostaurin in Indolent Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
University Medical Center Groningen 20
Large-scale testing (Phase 3)Study completedNCT00814073
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 135
Large-scale testing (Phase 3)UnknownNCT04333108
What this trial is testing

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

Who this might be right for
Indolent Systemic Mastocytosis
AB Science 140
Not applicableStudy completedNCT00769587
What this trial is testing

Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

Who this might be right for
Non Neoplastic ConditionPrecancerous Condition
Centre Hospitalier Universitaire, Amiens